Diagnosis and Treatment of Endometrial Cancer
According to the American Cancer Society (ACS), over 40,000 women are diagnosed with cancer of the uterine body each year in the United States. Approximately 95 percent of these uterine body cancers are endometrial cancers.
Stanford Expertise
Treatment for patients with endometrial cancer focuses on optimizing postoperative therapy. Meticulous surgical staging is initially conducted to determine the extent of spread of the tumor so that therapy can be more precisely tailored.
- The Stanford team employs various postoperative radiation regimens, as well as chemotherapy, for patents with certain high-risk histotypes. Our doctors are also examining wither conventional postoperative pelvic radiation confers specific benefits to ally patients, or whether more selective assessment is indicated.
- For patients with recurrent or advanced cancer, several highly active new chemotherapeutic agents as well as hormonal therapy are available.
- The first studies of papillary serous endometrial carcinoma, performed at Stanford, have identified this particularly virulent form of the cancer and determined that more aggressive therapeutic approaches are needed. Treatment includes whole abdominal radiotherapy in certain locally advanced-stage cases.
Trial Administration